Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 16 de 16
Filter
Add more filters










Publication year range
1.
Arch Esp Urol ; 69(10): 711-715, 2016 Dec.
Article in Spanish | MEDLINE | ID: mdl-28042792

ABSTRACT

OBJECTIVE: Multicystic nephroma (multilocular cystic nephroma, multilocular cyst) is a relatively rare benign neoplasm of the kidney. Most patients are asymptomatic and tumours are usually discovered incidentally. METHODS: Between 2010 and 2015, 2 patients with cystic nephroma at our institution were diagnosed and treated. Our study includes two new cases of cystic nephroma and a review of the literature about the differential diagnosis of a cystic renal mass. RESULTS: In this report we present two cases of multilocular cystic nephroma in a 75-year-old-female and a 33-year-old female. They were diagnosed clinically as a renal mass and surgery was performed. CONCLUSIONS: Surgery is the main treatment for cystic nephroma. The combination of clinical, biochemical and radiological features may help in lesion characterization, but only histology can provide the definite diagnosis. The differential diagnosis includes multilocular cystic renal cell carcinoma and cystic nephroblastoma.


Subject(s)
Kidney Neoplasms , Adult , Aged , Female , Humans , Kidney Neoplasms/diagnosis , Kidney Neoplasms/surgery
2.
Pathol Res Pract ; 196(8): 553-9, 2000.
Article in English | MEDLINE | ID: mdl-10982018

ABSTRACT

Cellular drug resistance and increased metastatic potential are the major obstacles in the successful treatment of cancer with chemotherapy. The aim of this study was to investigate whether the immunohistochemical expression of two proteins implicated in drug resistance (P-glycoprotein and metallothionein) and the product of the suppressor gene nm23 could be related to prognosis in breast cancer. Seventy-two patients with palpable or occult breast carcinoma, not treated with chemotherapy or endocrine therapy, were examined. Immunohistochemical methods were used to determine the expression of P-glycoprotein (PG), metallothionein (MT), nm23, as well as the estrogen receptor (ER), the p53 status, and the Ki67 index. The results were correlated with clinical and morphological features. Cytoplasmic and membrane-specific immunostainings of PG were seen exclusively in tumor cells and identified in 14 of 72 cases (19.4%). Only a statistically significant association with metastases, (p = 0.06) and recurrences (p = 0.1) was observed. MT-positive reaction was identified in the cytoplasm of the tumor cells in 47 (65.3%) cases. Statistical significance was associated with metastases (p = 0.07), but not with death or recurrences. Specific immunostaining of nm23 protein was seen only in the cytoplasm of tumor cells. A positive reaction was observed in 55 of 72 (89.3%) cases. Although a significant association between nm23 protein expression and other morphologic and immunohistochemical variables did not exist, we observed a higher morbidity in patients with the MT-positive/nm23-negative tumor phenotype. Univariate analysis for survival selected the following variables: histologic grade (p = 0.001), ER (p = 0.002), mitotic index (p = 0.005), Ki 67 index (p = 0.068), MT (p = 0.046) and PG (p = 0.085). The Cox model provided the following independent variables: histologic grade (p = 0.021) and metallothionein (p = 0.03). These data confirm the prognosis observed in patients with PG or metallothionein expression as well as the independence of these two variables. It also suggests that nm23 is not necessarily involved in the development of an invasive phenotype.


Subject(s)
ATP Binding Cassette Transporter, Subfamily B, Member 1/metabolism , Breast Neoplasms/metabolism , Carcinoma/metabolism , Metallothionein/metabolism , Monomeric GTP-Binding Proteins/metabolism , Nucleoside-Diphosphate Kinase , Transcription Factors/metabolism , Adult , Aged , Aged, 80 and over , Breast Neoplasms/pathology , Carcinoma/pathology , Female , Humans , Immunohistochemistry , Middle Aged , NM23 Nucleoside Diphosphate Kinases , Prognosis , Survival Analysis
3.
Acta Cytol ; 44(2): 259-64, 2000.
Article in English | MEDLINE | ID: mdl-10740618

ABSTRACT

BACKGROUND: Although mucoepidermoid carcinoma is considered a very rare, low grade thyroid neoplasm, in two patients a very rapid and aggressive outcome occurred. We describe the cytologic, histologic and immunohistochemical findings of a high grade mucoepidermoid carcinoma that evolved into an anaplastic carcinoma. CASE: A 57-year-old man was admitted with dysphagia, dysphonia and odynophagia. The patient had begun to develop symptoms over the previous two months. Ultrasound and computed tomography revealed diffuse enlargement of the thyroid gland with multiple, bilateral, palpable lymph nodes in the cervical, supraclavicular, paratracheal and retrocaval chains. The patient died four weeks after receiving the first cycle of treatment with adriamycin and cisplatin. The smears were highly cellular, with a background rich in neutrophilic, inflammatory infiltrate and necrotic debris. Two main types of tumor cell were identified: squamoid and mucus secreting. Squamoid cells were polygonal, with well-defined borders and dense cytoplasm. Nuclei varied greatly in shape and size and displayed clumped chromatin and prominent nucleoli. Mucussecreting cells were ring shaped and dispersed among the squamoid cells; they contained a large vacuole, with condensed acid and neutral mucins, that peripherally displaced the nucleus. Small and large clusters of large, polygonal cells with single or multiple bizarre nuclei and less-dense cytoplasm were also present. Histology revealed tumor cells distributed in irregular nests, with necrosis surrounded by a fibrous stroma. The predominant cells were squamoid, but dispersed mucus-secreting cells were frequently seen in the better-differentiated areas. Sparse anaplastic spindle cells were observed adjacent to the squamoid focus. Immunohistochemistry revealed a reaction positive for cytokeratin (AE3/AE1) in tumor nests and negative staining for thyroglobulin and neuroendocrine markers. CONCLUSION: Although mucoepidermoid carcinoma of the thyroid is a very rare neoplasm, its peculiar cytomorphologic features in fine needle aspiration cytology may contribute to its correct diagnosis.


Subject(s)
Biopsy, Needle , Carcinoma, Mucoepidermoid/pathology , Thyroid Neoplasms/pathology , Biomarkers, Tumor/analysis , Carcinoma, Mucoepidermoid/chemistry , Carcinoma, Mucoepidermoid/diagnostic imaging , Fatal Outcome , Humans , Immunohistochemistry , Keratins/analysis , Male , Middle Aged , Thyroid Neoplasms/chemistry , Thyroid Neoplasms/diagnostic imaging , Tomography, X-Ray Computed , Ultrasonography
4.
Pathol Res Pract ; 196(3): 167-74, 2000.
Article in English | MEDLINE | ID: mdl-10729921

ABSTRACT

Apoptosis may play a major role in determining tumor growth and aggressiveness. The aim of this study was to examine the relationship between apoptosis, expression of bcl-2 and p53 proteins, proliferation index, and other clinicopathological features of breast carcinoma. Sixty-five formalin-fixed paraffin-embedded tissue sections from invasive ductal breast carcinomas were studied for the presence of apoptosis by the terminaldeoxynucleotidyl-transferase-mediated dUTP-FITC nick end-labeling (TUNEL) method. Immunohistochemical methods were also used to determine the expression of estrogen receptor, Ki67, bcl-2 and p53 proteins. The number of apoptotic cells ranged from 2.0 to 236.0/10HPF (mean 36.26, median 28.0). The observation of 30 apoptotic cells/10HPF was more common in tumors > 3 cm, of histological grade III, with a high mitotic index, Ki67 index > or = 300, and p53 positivity; however, statistical significance was found only for the histological grade. Grade I and III tumors displayed an inverse association between the apoptotic index and bcl-2 and p53 protein expressions; grade I tumors frequently expressed bcl-2 (19/28), lacked p53 (20/28), and presented a low number of apoptotic cells (18/28), whereas grade III tumors tended to express p53 (12/17), lacked bcl-2 (13/17), and displayed a high number of apoptotic cells/10HPF (12/17). Multivariate analysis for survival revealed that estrogen receptors and apoptosis were independent variables. These data suggest that apoptosis, rather than proliferation index or expression of bcl-2 or p53 proteins, is an independent factor for the prognosis of survival.


Subject(s)
Apoptosis , Breast Neoplasms/pathology , Carcinoma, Ductal, Breast/pathology , Adult , Aged , Aged, 80 and over , Breast Neoplasms/metabolism , Breast Neoplasms/mortality , Carcinoma, Ductal, Breast/metabolism , Carcinoma, Ductal, Breast/mortality , Female , Humans , Immunoenzyme Techniques , In Situ Hybridization , In Situ Nick-End Labeling , Ki-67 Antigen/metabolism , Middle Aged , Neoplasm Recurrence, Local , Neoplasm Staging , Proto-Oncogene Proteins c-bcl-2/metabolism , Receptors, Estrogen/metabolism , Survival Rate , Tumor Suppressor Protein p53/metabolism
6.
J Laryngol Otol ; 113(6): 581-4, 1999 Jun.
Article in English | MEDLINE | ID: mdl-10605595

ABSTRACT

A case of melanotic neuroectodermal tumour of infancy is described. The pre-operative diagnosis was made on cytological material obtained by fine needle aspiration. The patient was a three-month-old male infant with a rapidly growing maxillary tumour mass that also involved the pterygomaxillary fossae and the floor of the orbit. In addition to the typical clinical presentation, the cytology is also distinctive showing a dual population of small neuroblastic cells and large melanin-containing epithelial cells. Histological, immunohistochemical and electron microscopic examination of the excised mass confirmed the initial diagnosis. The pre-operative distinction of this tumour from other small round cell tumours of infancy (rhabdomyosarcoma, neuroblastoma, melanoma and lymphoma), is essential in order to plan the most complete resection therefore reducing the possibilities of tumour recurrence. This tumour belongs to a field of pathology with which many otolaryngologists may not be familiar.


Subject(s)
Maxillary Neoplasms/pathology , Neuroectodermal Tumor, Melanotic/pathology , Biopsy, Needle , Humans , Infant , Male , Maxillary Neoplasms/surgery , Microscopy, Electron , Neuroectodermal Tumor, Melanotic/surgery , Tomography, X-Ray Computed
8.
Arch Pathol Lab Med ; 122(11): 957-65, 1998 Nov.
Article in English | MEDLINE | ID: mdl-9822123

ABSTRACT

Alteration of cell-surface blood group antigens during malignant transformation is a well-known phenomenon that has not yet been sufficiently investigated in thyroid gland neoplasms. We evaluated 50 normal thyroid glands and 141 differentiated thyroid neoplasms (29 follicular adenomas, 30 follicular carcinomas, 56 papillary carcinomas, and 26 medullary carcinomas) both by the immunoperoxidase technique, using monoclonal antibodies against blood group antigens (A, B, H, Le(a), Le(b), Le(x), and Le(y)) and precursor substances (T, Tn, and sTn), and by affinity to the lectin from Arachis hypogea, to determine the usefulness of these antigens as tumor markers and prognostic factors. Neoplastic tissues showed immunostaining with concordant and nonconcordant expression of ABH antigens. There were statistically significant differences between normal and neoplastic tissues but not among the different neoplasms. Statistically significant differences in Lewis antigen expression were noted between normal and neoplastic tissues and between benign and malignant tumors. Tn and sTn antigen expression showed statistically significant differences between normal and neoplastic tissues. In conclusion, blood group antigens are tumor markers that are expressed more frequently in malignant than in benign neoplasms. The presence of metastases was correlated with enhanced peanut lectin receptors and a loss of A or B antigens.


Subject(s)
ABO Blood-Group System/analysis , Adenocarcinoma, Follicular/chemistry , Adenoma/chemistry , Carcinoma, Medullary/chemistry , Carcinoma, Papillary/chemistry , Thyroid Neoplasms/chemistry , Adenocarcinoma, Follicular/pathology , Adenoma/pathology , Antibodies, Monoclonal , Antigens, Tumor-Associated, Carbohydrate/analysis , Biomarkers, Tumor , Carcinoma, Medullary/pathology , Carcinoma, Papillary/pathology , Female , Humans , Immunoenzyme Techniques , Male , Prognosis , Thyroid Gland/chemistry , Thyroid Neoplasms/pathology
10.
Article in English | MEDLINE | ID: mdl-8653466

ABSTRACT

Two cases of non-Hodgkin's lymphoma that show a sarcomatoid pattern within the jaw are described. Their primary origin in bone was demonstrated by radiologic studies. In one case, diagnosis was delayed because the clinical picture suggested inflammatory periodontal disease. In both cases, the histologic picture was similar to that of a sarcomatoid neoplasm with intense stromal sclerosis; hemimandibulectomy was performed in one case. The tumor contained cells with large, irregular, sometimes lobulated nuclei and high mitotic activity, and perforated mandibular bone with infiltration into adjacent soft tissues. The lymphoid nature of these neoplasms was demonstrated by immunohistochemical and ultrastructural study.


Subject(s)
Lymphoma, B-Cell/pathology , Lymphoma, Large B-Cell, Diffuse/pathology , Mandibular Neoplasms/pathology , Humans , Immunoenzyme Techniques , Male , Middle Aged , Sclerosis
11.
Dermatol Surg ; 22(1): 83-7, 1996 Jan.
Article in English | MEDLINE | ID: mdl-8556263

ABSTRACT

BACKGROUND: Small, well-differentiated groups of nevus cells have been found occasionally in the marginal sinuses and parenchyma of regional lymph nodes that drain sites of cellular blue nevi. OBJECTIVE: The histologic, immunohistochemical, and karyometric description of a pigmented cutaneous lesion, with the features of cellular blue nevus and located on the leg of a 14-year-old woman, that was accompanied by synchronic presentation of massive inguinal lymph-node metastases. METHODS: The excised specimens were processed routinely, embedded in paraffin, and sectioned into 4-microm-thick slices. The sections were stained using hematoxylin-eosin and the ABC immunohistochemical method for demonstrating S-100 and HMB-45. Karyometric analysis was performed in a static cytometer using Feulgen-stained sections. RESULTS: The cutaneous lesion had the cytologic and architectural features of cellular blue nevus. The lymph nodes showed massive invasion by pigmented cells and contained extensive necrotic foci. After 3.5 years of clinical follow-up, the patient is free from disease. CONCLUSIONS: The absence of malignant features in the cutaneous lesion and the bland nuclear features of the pigmented cells in the regional lymph node metastases suggest that this case could be interpreted as an unusual form of benign cellular blue nevus with metastases. Nonetheless, other possibilities, such as malignant melanoma mimicking a cellular blue nevus or primary malignant melanoma of the lymph nodes with concomitant cutaneous cellular blue nevus, cannot be definitively excluded. A conservative surgical approach with close follow-up was recommended.


Subject(s)
Nevus, Blue/secondary , Skin Neoplasms/pathology , Adolescent , Female , Humans , Leg , Lymphatic Metastasis
12.
Acta Cytol ; 39(3): 550-4, 1995.
Article in English | MEDLINE | ID: mdl-7762351

ABSTRACT

Giant cell tumors of bone are neoplasms with potential local and systemic aggressiveness. A case of giant cell tumor with radiologic and histologic features suggestive of locally aggressive behavior is reported. Cytologic material was obtained by fine needle aspiration from an intraosseous tumor that destroyed the cortex and from the invaded, adjacent soft tissues. The smears from the osseous aspirate showed the typical cytologic features of giant cell tumor, whereas the invaded tissues had a prominent loss of cohesiveness between mononucleate and giant cells. In addition, mitotic figures in the mononucleate component were noticeable. The differential diagnosis based on clinical and cytologic findings is discussed.


Subject(s)
Bone Neoplasms/diagnosis , Giant Cell Tumor of Bone/diagnosis , Biopsy, Needle , Bone Cysts, Aneurysmal/diagnosis , Bone Cysts, Aneurysmal/pathology , Bone Neoplasms/diagnostic imaging , Bone Neoplasms/pathology , Chondroblastoma/diagnosis , Chondroblastoma/pathology , Diagnosis, Differential , Female , Giant Cell Tumor of Bone/diagnostic imaging , Giant Cell Tumor of Bone/pathology , Humans , Middle Aged , Neoplasm Invasiveness , Osteoblastoma/diagnosis , Osteoblastoma/pathology , Radiography
13.
J Laryngol Otol ; 109(1): 63-5, 1995 Jan.
Article in English | MEDLINE | ID: mdl-7876743

ABSTRACT

Haemangiopericytoma and glomus tumours are infrequent neoplasms in otorrhinolaryngology. A case of glomus tumour with haemangiopericytomatous features of the left amygdalar fossa is reported. Its clinical, surgical and histological features are described. This case report supports the unitary concept of smooth muscle tumours of the small vascular wall.


Subject(s)
Glomus Tumor/pathology , Hemangiopericytoma/pathology , Neoplasms, Multiple Primary/pathology , Oropharyngeal Neoplasms/pathology , Aged , Female , Humans
14.
Pathol Res Pract ; 190(6): 627-35, 1994 Jun.
Article in English | MEDLINE | ID: mdl-7984522

ABSTRACT

Blue nevus is an uncommon pigmented lesion of dermal melanocytes. By convention, two well defined histologic variants, designated as "common" and "cellular", have been recognised. In the last few years, these lesions have attracted much attention due to the recognition of news entities and to its confusion with malignant melanoma. In the present review, we point out the more striking features of new related entities (combined nevus, deep penetrating nevus, compound blue nevus) and establish the differential diagnosis with conflictive lesions such as atypical blue nevus, locally aggressive blue nevus, congenital giant melanocytic nevus with nodular growth and melanocytic dermal tumor of unpredictable outcome. We also review the concept of malignant blue nevus and the significance of lymph node metastases. The blue nevus is an uncommon pigmented lesion consisting of dermal melanocytes that can appear in diverse forms: dendritic, spindle-shaped, oval-shaped, or polyhedral. Although it usually occurs in skin, it has been reported in other locations, such as oral mucosa, sclera, uterine cervix, vagina, prostate, spermatic cord, pulmonary hilus, orbit, conjunctiva, maxillary sinus, breast, and lymph nodes 3,8,42,49. Generally, it occurs in adults as a single, acquired, intensely pigmented lesion, although familial and multiple nevi have been reported 7,39. By convention, there are two well-defined histologic variants, designated as "common" and "cellular", but lesions often manifest intermediate features. In the last few years, blue nevus has attracted much attention due to the recognition of new (clinical and histologic) entities and to its confusion with malignant melanoma.(ABSTRACT TRUNCATED AT 250 WORDS)


Subject(s)
Nevus, Blue/pathology , Skin Neoplasms/pathology , Diagnosis, Differential , Female , Humans , Lymph Nodes/pathology , Lymphatic Metastasis , Male
15.
Acta Cytol ; 37(6): 938-42, 1993.
Article in English | MEDLINE | ID: mdl-8249517

ABSTRACT

Metastatic glioblastoma multiforme is a rare event usually seen in patients with previous and repeated surgery. Fine needle aspiration from enlarged lymph nodes in a patient with cerebral glioblastoma multiforme showed a highly cellular smear with dispersed single cells and cell clusters. The cells had marked pleomorphism, hyperchromasia, coarse chromatin, prominent nucleoli and occasional intranuclear cytoplasmic inclusions. Multinucleate giant cells and marked endothelial proliferation were also seen. The diagnosis of metastatic glioblastoma multiforme was supported by immunohistochemistry, which showed many cells with thick and large cytoplasmic processes with intense immunoreactivity to glial fibrillary acid protein. The differential diagnosis with other metastatic small cell tumors is discussed.


Subject(s)
Cervical Vertebrae , Glioblastoma/secondary , Lymphatic Metastasis/diagnosis , Lymphatic Metastasis/pathology , Lymphoma/diagnosis , Lymphoma/pathology , Biopsy, Needle , Glial Fibrillary Acidic Protein/analysis , Glioblastoma/diagnosis , Glioblastoma/pathology , Humans , Immunohistochemistry , Lymph Nodes/chemistry , Lymph Nodes/pathology , Male , Middle Aged
16.
Article in English | MEDLINE | ID: mdl-8116223

ABSTRACT

In cortical adrenal gland tumours there are discrepancies between morphological criteria for malignancy and biological behaviour. This makes it difficult to select the appropriate treatment. We have studied morphometric and DNA densitometric features of 24 adrenal proliferative lesions (hyperplasia, adenoma, and carcinoma) by means of slide cytometry. All variables have been correlated with pathological diagnosis. The samples were selected from paraffin-embedded tissue, and representative lesions were Feulgen stained. Densitometric study showed aneuploid cell lines in every carcinoma, 5 of 8 adenomas, and 5 of 10 hyperplastic lesions. Both DNA nuclear content (mean ploidy of 2.11 c, 2.41 c, and 3.05 c) mean nuclear area (average of 31.26 microns 2, 35.92 microns 2, and 42.39 microns 2) showed progressive increase from hyperplasia to adenoma, and carcinoma. Mean shape factors were lowest in adenomas (1.69) and highest in carcinomas (1.82). Those karyometric variables which showed statistically significant differences (p < 0.05) among diagnostic groups were included in a stepwise three-way discriminant analysis. Only three parameters, shape factor (p = 0.0008), mean ploidy (p = 0.0012), and adrenal weight (p = 0.0055) persisted as independent predictive factors. Using the three variables selected by discriminant analysis on our cases, 100% of the adenomas were correctly classified, 83% of the carcinomas, and 80% of the hyperplasias. Tumour weight and nuclear shape factor differentiated adrenal cortex adenoma from carcinoma, while mean ploidy distinguished adrenal cortical hyperplasia from carcinoma. Nuclear pleomorphism (shape factor) and DNA-ploidy are the most important nuclear features in predicting the biological course of proliferative adrenal cortex lesions, although by themselves they are not bona-fide discriminators.


Subject(s)
Adrenal Cortex Diseases/genetics , Cell Nucleus/metabolism , DNA/metabolism , Adenoma/genetics , Adenoma/pathology , Adrenal Cortex/pathology , Adrenal Cortex Diseases/pathology , Adrenal Cortex Neoplasms/genetics , Adrenal Cortex Neoplasms/pathology , Adult , Carcinoma/genetics , Carcinoma/pathology , Child , Densitometry , Discriminant Analysis , Female , Humans , Hyperplasia , Male , Middle Aged , Ploidies
SELECTION OF CITATIONS
SEARCH DETAIL
...